Comparison of intraoperative intravenous anesthetic agents (propofol and remimazolam) in patients with lung cancer :prospective cohort study
Not Applicable
Recruiting
- Conditions
- ung cancer patients
- Registration Number
- JPRN-UMIN000044009
- Lead Sponsor
- Department of anesthesiology and pain medicine, Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients whose consent was not obtained. Patients who are taking immunosuppressive drugs or steroids. Patients who have already received chemoradiation therapy. Simultaneous bilateral surgery. Patients with autoimmune diseases such as collagen diseases. Cardiac disease of NYHA III degree or higher. Respiratory dysfunction with a VC or FEV1 of less than 50%. Pulmonary hypertension with mean pulmonary artery pressure of 30 mmHg or more. Highly obese patients with BMI greater than 30. Severe hepatic or renal dysfunction. Patients with allergy to propofol or benzodiazepine anesthetics. Other patients who are judged by the principal investigator to be inappropriate as research subjects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Partial pressure of arterial blood oxygen during one-lung ventilation
- Secondary Outcome Measures
Name Time Method Evaluation of awakening Immunosuppressive effect